It is common to use the ratio of CD4+/CD8+ T cells as a surrogate marker for immune competence in HIV infection and when this ratio falls or remains below 1.0, there is a higher risk for non-AIDS related adverse clinical events [105]. This evidence concerns the gene CD4 and HIV infectious disease.